See the Complete Picture.
Get Started
SubscribeLogin
Israel-Hamas Conflict
G7
Juneteenth
Artificial Intelligence
War
Social Media
Stock Markets
World Cup
Military
Soccer
Donald Trump
Drones
Education
go2.org image

News from go2.org

We’ve assigned a rating of Unknown factuality to go2.org. You can read more about how we’ve determined go2.org’s credibility and reliability as a news source here: https://ground.news/rating-system.

Information about go2.org

Where is go2.org located?go2.org's Website

Media Bias Ratings

Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.

Factuality

Learn more about  Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about  Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top go2.org News

Next-Generation TKI Approved for Advanced ROS1-Positive Lung Cancer
Pharma · United States

Next-Generation TKI Approved for Advanced ROS1-Positive Lung Cancer

100% Center coverage: 2 sources
(MedPage Today) -- The FDA approved taletrectinib (Ibtrozi) -- a next-generation oral ROS1 tyrosine kinase inhibitor (TKI) -- for the treatment of adults with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC)...See the Story
A Mother and Son on a Mission: Rina’s Story - GO2 for Lung Cancer
Andalusia, Spain · Andalusia

A Mother and Son on a Mission: Rina’s Story - GO2 for Lung Cancer

Rina A. grew up on a corn farm in Nebraska and now lives in Debary, FL, with her soulmate and husband, John. She has worked at Stetson University for 20 years and is currently the presidential liaison for philanthropic and strategic partnerships for the university. Her son, Michey, grew up in Orlando, FL, and now resides in Washington, D.C., where he serves as a senior government affairs policy professional at Revvity, a leading life sciences an…See the Story
FDA Grants Priority Review to Zepzelca Combo for Small Cell Lung Cancer
United States · United States

FDA Grants Priority Review to Zepzelca Combo for Small Cell Lung Cancer

FDA granted priority review to Zepzelca plus Tecentriq for first-line maintenance in extensive-stage small cell lung cancer.See the Story

As Time Is Ticking, Our Government Could Be Returning to Funding Levels from Decades Ago! - GO2 for Lung Cancer

We are deeply concerned that the President’s Fiscal Year 2026 (FY26) budget does not reflect the public’s call for sustained and robust investments in cancer research. Instead, it threatens to reverse decades of progress. On Friday, May 30, 2025, the Department of Health and Human Services (HHS) released its Fiscal Year 2026 Budget in Brief, which proposes drastic cuts to key federal health agencies, including the National Institutes of Health (…Cancer · United StatesRead Article

A Family’s Tribute Turns into a Powerful Fundraiser - GO2 for Lung Cancer

In an extraordinary display of dedication, heart, and hoop talent, sisters Sophie and Emma Zirkin—2 standout high school basketball players from Maryland—turned their grief into action by shooting 10,000 3-pointers to raise funds for lung cancer research. The effort, which honored their grandmother who passed away from lung cancer, became a moving tribute, raising money for GO2 for Lung Cancer.  Over the course of 36 hours, the Zirkins, alongsid…Cancer · MarylandSee the Story

From Doctor to Patient: Dr. Lin's Story - GO2 for Lung Cancer

When Dr. Bryant Lin noticed a persistent cough and an unusual tightness in his throat last spring, he didn’t panic. A busy primary care doctor, clinical professor at Stanford Medicine, and co-director of Stanford’s Center for Asian Health Research and Education (CARE), he chalked it up to allergies or a cold. He was just weeks away from turning 50, in good health, and had never smoked a day in his life.  But something wasn’t right.   When inhale…Stanford · StanfordRead Article

Strengthening State Plans to Fight Lung Cancer: A Roadmap for Action - GO2 for Lung Cancer

Lung cancer remains the leading cause of cancer deaths in every state, nationwide. In 2025, it is estimated that more people will die from lung cancer than from breast and colorectal cancers combined. Despite this fact, lung cancer continues to be underrepresented in many state cancer control efforts. Every state prepares a comprehensive cancer control (CCC) plan supported through the National Comprehensive Cancer Control Program (NCCCP), housed…United States · United StatesRead Article

Lung Cancer and Women: A Q&A with Narjust Florez, MD - GO2 for Lung Cancer

To honor Women’s Health Month, we sat down with Narjust Florez, MD, to discuss how lung cancer uniquely affects women. Research shows that women often face different—and sometimes more severe—experiences with lung cancer than men. These differences happen because of biology and because women haven’t been included in clinical trials as much in the past, which affects how new treatments are created and prescribed to patients.  Women are also more …Maryland · MarylandRead Article

Margaret Richardson and Karen Mostes-Withrow Join GO2 for Lung Cancer Board of Directors

New members bring bold leadership and lived experience to accelerate progress for the lung cancer community WASHINGTON, DC, UNITED STATES, May 19, 2025 /EINPresswire.com/ -- GO2 for Lung Cancer (GO2) proudly announces the appointment of two new members to its Board of Directors: Margaret Richardson, chief corporate affairs officer at GoFundMe, and Karen Mostes-Withrow, a seasoned operations leader and 17-year lung cancer survivor. Both bring a w…Washington State · WashingtonSee the Story

FDA OKs New Drug for Lung Cancer With c-Met Overexpression

100% Center coverage: 1 sources
(MedPage Today) -- The FDA granted accelerated approval to telisotuzumab vedotin (Emrelis) for the treatment of adults with previously treated, locally advanced, or metastatic non-squamous non-small cell lung cancer (NSCLC) with high c-Met protein...FDA · United StatesSee the Story

Trump’s budget proposes steep cuts to NIH, health funding

63% Center coverage: 152 sources
The White House on Friday revealed President Trump’s budget request for fiscal 2026, which includes cutting a quarter of the discretionary funding designated to the Department of Health and Human Services (HHS). US Politics · United StatesSee the Story

Breaking News Topics Related to go2.org

Washington State

Washington State

United States

United States

Maryland

Maryland

Cancer

Cancer

News
For You
SearchBlindspotLocal